Back to feed
SYRESpyre Therapeutics, Inc.
CIK 0001636282 · last filing 2d ago · 4 insider transactions
Buy volume
$217.5K
2 buy transactions
Sell volume
$1.31M
2 sell transactions
Net flow
-$1.09M
Net selling
Total flow
$1.52M
4 priced transactions
Disclosure radarcross-source convergence
Institution-led3/5 sources
0/100
Recent disclosures · timeline
- Form 42d ago
Chief Financial Officer · sold $1.09M
- Form 1443d ago
Proposed sale of 15,000 sh ($1.31M) · discretionary
Price · SYRE
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
SYRE insider flow· last 30 days
Buys Sellsnet -$1.09M
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data1 fund holds$278.49M reported valueNet reducing(0 adding · 1 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| BlackRock Inc | 5,521,221 | $278.49M | 0.0% | Trim |
Proposed sales · Form 144
selling intent · live SEC data1 notice$1.31M proposed to sell0/1 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 3d ago | SCOTT BURROWS Officer | 15,000 | $1.31M | Jun 25, 2026 | Stock Option Exercise | Discretionary |
Recent insider transactions
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
2d ago Jun 25, 2026 | Burrows Scott L Chief Financial Officer | Buy · M | 15,000 | $0.00 | $0 | Mild sell-16 | Deriv | |
2d ago Jun 25, 2026 | Burrows Scott L Chief Financial Officer | Sell · S | 10,000 | $87.14 | $871.4K | Mild sell-16 | ||
2d ago Jun 25, 2026 | Burrows Scott L Chief Financial Officer | Sell · S | 5,000 | $87.12 | $435.6K | Mild sell-16 | ||
2d ago Jun 25, 2026 | Burrows Scott L Chief Financial Officer | Buy · M | 15,000 | $14.50 | $217.5K | Mild sell-16 |